diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/DM2014247-55diaendo-6400Research ArticleКардиологияCardiologyВлияние факторов роста фибробластов и конечных продуктов гликирования на толщину комплекса интима-медиа у больных с ишемической болезнью сердца и сахарным диабетом 2 типаThe effect of fibroblast growth factors and advanced glycation end-products on the intima-media complex thickness in patients with coronary heart disease and type 2 diabetesИванниковаЕкатерина ВладимировнаIvannikovaEkaterina Vladimirovna

аспирант Института Диабета

graduate student

doc.ivannikova@gmail.comКалашниковВиктор ЮрьевичKalashnikovVictor Yurievich

доктор медицинских наук, заведующий отделением неотложной и интервенционной кардиологии

MD, PhD, Head of the Interventional Cardiology Department of the Diabetes institute

victor9368@gmail.comСмирноваОльга МихайловнаSmirnovaOlga Mikhailovna

доктор медицинских наук, профессор, главный научный сотрудник Отделения программногообучения и лечения Института диабета

Md, PhD, Professor, Cheif Researcher in Programme Education and reatment department of the Diabetes institute

dr_smr@mail.ruКузнецовАлександр БорисовичKuznetsovAlexander Borisovich

кандидат медицинских наук, врач отделения кардиологии

MD, PhD, Diabetes institute

doc.ivannikova@gmail.comТерёхинСергей АнатольевичTerekhinAnatolievich

MD, PhD, Head of the X-ray diagnostic and treatment department of the Diabetes Institute

doc.ivannikova@gmail.comИльинАлександр ВикторовичIl'inAlexander Viktorovich

заведующий лабораторией

MD, Head of Laboratory department

doc.ivannikova@gmail.comФГБУ "Эндокринологический научный центр" Минздрава России, МоскваРоссияEndocrinology Research Centre, MoscowRussian Federation2014070520141724755Copyright © Иванникова Е.В., Калашников В.Ю., Смирнова О.М., Кузнецов А.Б., Терёхин С.А., Ильин А.В., 20142014Иванникова Е.В., Калашников В.Ю., Смирнова О.М., Кузнецов А.Б., Терёхин С.А., Ильин А.В.Ivannikova E.V., Kalashnikov V.Y., Smirnova O.M., Kuznetsov A.B., Терёхин С.А., Il'in A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/6400факторы роста фибробластовкомплекс интима-медиаконечные продукты гликированиясахарный диабетатеросклерозfibroblast growth factorsintima-media complexadvanced glycation end-productsdiabetesatherosclerosisФГБУ Эндокринологический научный центр, МоскваEndocrinology Research Centre, MoscowReferencesAjani UA, Ford ES. Has the risk for coronary heart disease changed among U.S. adults? J Am Coll Cardiol. 2006;48:1177-1182.Ajani UA, Ford ES. Has the risk for coronary heart disease changed among U.S. adults? J Am Coll Cardiol. 2006;48:1177-1182.Sang Ouk Chin, Jin Kyung Hwang, Sang Youl Rhee, Suk Chon, You-Cheol Hwang, Seungjoon Oh, Kyu Jeung Ahn, Ho Yeon Chung, Jeong-taek Woo, Sung-Woon Kim, Young Seol Kim, Ja-Heon Kang, In-Kyung Jeong. Risk Factors for the Progression of Intima-Media Thickness of Carotid Arteries: A 2-Year Follow-Up Study in Patients with Newly Diagnosed Type 2 Diabetes. Diabetes Metab J. 2013 October; 37(5): 365–374.Sang Ouk Chin, Jin Kyung Hwang, Sang Youl Rhee, Suk Chon, You-Cheol Hwang, Seungjoon Oh, Kyu Jeung Ahn, Ho Yeon Chung, Jeong-taek Woo, Sung-Woon Kim, Young Seol Kim, Ja-Heon Kang, In-Kyung Jeong. Risk Factors for the Progression of Intima-Media Thickness of Carotid Arteries: A 2-Year Follow-Up Study in Patients with Newly Diagnosed Type 2 Diabetes. Diabetes Metab J. 2013 October; 37(5): 365–374.Pignoli P, Tremoli E, Poli A. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74(6): 1399-406.Pignoli P, Tremoli E, Poli A. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74(6): 1399-406.Bots ML, Baldassarre D, Simon A, de Groot E, O'Leary DH, Riley W, Kastelein JJ, Grobbee DE. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations? Eur Heart J. 2007 Feb;28(4):398-406.Bots ML, Baldassarre D, Simon A, de Groot E, O'Leary DH, Riley W, Kastelein JJ, Grobbee DE. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations? Eur Heart J. 2007 Feb;28(4):398-406.Eleid MF, Lester SJ, Wiedenbeck TL. Carotid ultrasound identifies high risk subclinical atherosclerosis in adults with low framingham risk scores. J Am Soc Echocardiogr. 2010;23(8):802-808.Eleid MF, Lester SJ, Wiedenbeck TL. Carotid ultrasound identifies high risk subclinical atherosclerosis in adults with low framingham risk scores. J Am Soc Echocardiogr. 2010;23(8):802-808.Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007 Jan 30;115(4):459-67.Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007 Jan 30;115(4):459-67.Tarzamni MK, Salehi R, Givian F, Farhang S. Association of carotid intima-media thickness with the presence and severity of coronary artery disease. Neurosciences 2006;11(4): 308-311.Tarzamni MK, Salehi R, Givian F, Farhang S. Association of carotid intima-media thickness with the presence and severity of coronary artery disease. Neurosciences 2006;11(4): 308-311.Bots M.L., Hoes A.W. Koudstaal P.J., Hofman A., Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation, 1997; 96(5): 1432-1437.Bots M.L., Hoes A.W. Koudstaal P.J., Hofman A., Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation, 1997; 96(5): 1432-1437.Simons PC, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol. 1999 Oct;15(9):773-81.Simons PC, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol. 1999 Oct;15(9):773-81.Белоусов ЮБ, Несмараев ЖН. Эндотелиальная дисфункция как причина атеросклеротического поражения артерий при артериальной гипертензии. Фарматека.2004;6(84):62-72Белоусов ЮБ, Несмараев ЖН. Эндотелиальная дисфункция как причина атеросклеротического поражения артерий при артериальной гипертензии. Фарматека.2004;6(84):62-72Campistol JM, Inigo P, Jimenez W. Losartan decreases plasma levels of TGF-pi in transplant patients with chronic allograft nephropathy. Kidney Int.1999;56:714-719.Campistol JM, Inigo P, Jimenez W. Losartan decreases plasma levels of TGF-pi in transplant patients with chronic allograft nephropathy. Kidney Int.1999;56:714-719.Herder M, Johnsen SH, Arntzen KA, Mathiesen EB. Risk factors for progression of carotid intimamedia thickness and total plaque area. А 13-year follow-up study: the Tromso study. Stroke. 2012;43(7):1818–1823.Herder M, Johnsen SH, Arntzen KA, Mathiesen EB. Risk factors for progression of carotid intimamedia thickness and total plaque area. А 13-year follow-up study: the Tromso study. Stroke. 2012;43(7):1818–1823.Ingelsson E, Sullivan LM, Murabito JM, Fox CS, Benjamin EJ, Polak JF, Meigs JB, Keyes MJ, O’Donnell CJ, Wang TJ, D’Agostino RB Sr, Wolf PA, Vasan RS. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes. 2007;56(6):1718— 1726.Ingelsson E, Sullivan LM, Murabito JM, Fox CS, Benjamin EJ, Polak JF, Meigs JB, Keyes MJ, O’Donnell CJ, Wang TJ, D’Agostino RB Sr, Wolf PA, Vasan RS. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes. 2007;56(6):1718— 1726.Zieman SJ, Vojtech M, Clattenburg L, Corretti MC, Capriotti AR, Gerstenblith G, Kass DA. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens. 2007;25:577-83Zieman SJ, Vojtech M, Clattenburg L, Corretti MC, Capriotti AR, Gerstenblith G, Kass DA. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens. 2007;25:577-83Балахонова ТВ, Трипотень МИ, Погорелова ОА. Ультразвуковые методы оценки комплекса интима-медиа артериальной стенки. SonoAce-Ultrasound. 2010;21.Балахонова ТВ, Трипотень МИ, Погорелова ОА. Ультразвуковые методы оценки комплекса интима-медиа артериальной стенки. SonoAce-Ultrasound. 2010;21.Sauvage M, Hinglais N, Mandet C, Badier C, Deslandes F, Michel JB Jacob MP. Localization of elastin mRNA and TGF-ß1 in rat aorta and caudal artery as a function of age. Cell Tissue Res. 1998;291:305-14Sauvage M, Hinglais N, Mandet C, Badier C, Deslandes F, Michel JB Jacob MP. Localization of elastin mRNA and TGF-ß1 in rat aorta and caudal artery as a function of age. Cell Tissue Res. 1998;291:305-14Fleenor BS, Seals DR, Zigler ML, Sindler AL. Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice. Aging Cell. 2012;11:269-276.Fleenor BS, Seals DR, Zigler ML, Sindler AL. Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice. Aging Cell. 2012;11:269-276.Fleenor BS, Sindler AL, Eng JS, Nair DP, Dodson RB, Seals DR. Sodium nitrite de-stiffening of large elastic arteries with aging: Role of normalization of advanced glycation end-products. Exp Gerontol. 2012; 47:588-94.Fleenor BS, Sindler AL, Eng JS, Nair DP, Dodson RB, Seals DR. Sodium nitrite de-stiffening of large elastic arteries with aging: Role of normalization of advanced glycation end-products. Exp Gerontol. 2012; 47:588-94.Fleenor BS, Marshall KD, Durrant JR, Lesniewski LA, Seals DR. Arterial stiffening with ageing is associated with transforming growth factor-β1-related changes in adventitial collagen: reversal by aerobic exercise. J Physiol. 2010;588:3971-82.Fleenor BS, Marshall KD, Durrant JR, Lesniewski LA, Seals DR. Arterial stiffening with ageing is associated with transforming growth factor-β1-related changes in adventitial collagen: reversal by aerobic exercise. J Physiol. 2010;588:3971-82.Fleenor BS, Marshall KD, Rippe C, Seals DR. Replicative aging induces endothelial to mesenchymal transition in human aortic endothelial cells: Potential role of inflammation. J Vasc Res. 2012;49:59-64Fleenor BS, Marshall KD, Rippe C, Seals DR. Replicative aging induces endothelial to mesenchymal transition in human aortic endothelial cells: Potential role of inflammation. J Vasc Res. 2012;49:59-64Tiyyagura SR, Pinney SP. Left ventricular remodeling after myocardial infarction: past, present, and future. Mt. Sinai J. Med. 2006;73(6):840–851Tiyyagura SR, Pinney SP. Left ventricular remodeling after myocardial infarction: past, present, and future. Mt. Sinai J. Med. 2006;73(6):840–851Keeley EC, Mehrad B, Strieter RM. Fibrocytes: Bringing new insights into mechanisms of inflammation and fibrosis. International J. Biochemistry Cell Biology.2010;42:535-542.Keeley EC, Mehrad B, Strieter RM. Fibrocytes: Bringing new insights into mechanisms of inflammation and fibrosis. International J. Biochemistry Cell Biology.2010;42:535-542.Jandeleit-Dahm K, Cooper ME. The role of AGEs in cardiovascular disease. Curr Pharm Des. 2008;14(10):979-86.Jandeleit-Dahm K, Cooper ME. The role of AGEs in cardiovascular disease. Curr Pharm Des. 2008;14(10):979-86.Baumann M, Richart T, Sollinger D, Pelisek J, Roos M, Kouznetsova T, Eckstein H, we Heemann, Staessen JA. Association between carotid diameter and the advanced glycation endproduct Nε-Carboxymethyllysine (CML). Cardiovascular Diabetology.2009;8(1):45 doi:10.1186/1475-2840-8-45Baumann M, Richart T, Sollinger D, Pelisek J, Roos M, Kouznetsova T, Eckstein H, we Heemann, Staessen JA. Association between carotid diameter and the advanced glycation endproduct Nε-Carboxymethyllysine (CML). Cardiovascular Diabetology.2009;8(1):45 doi:10.1186/1475-2840-8-45Steppan J, Tran H, Benjo AM, Pellakuru L, Barodka V, Ryoo S, Nyhan SM, Lussman C, Gupta G, White AR, Daher JP, Shoukas AA, Levine BD. Alagebrium in combination with exercise ameliorates age-associated ventricular and vascular stiffness. Exp Gerontol. 2012;47:565-72.Steppan J, Tran H, Benjo AM, Pellakuru L, Barodka V, Ryoo S, Nyhan SM, Lussman C, Gupta G, White AR, Daher JP, Shoukas AA, Levine BD. Alagebrium in combination with exercise ameliorates age-associated ventricular and vascular stiffness. Exp Gerontol. 2012;47:565-72.Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern DM, Schmidt AM, De Caterina R. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation.2002;105:816-22.Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern DM, Schmidt AM, De Caterina R. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation.2002;105:816-22.Halushka MK, Selvin E, Lu J, Macgregor AM, Cornish TC. Use of human vascular tissue microarrays for measurement of advanced glycation endproducts. J Histochem Cytochem.2009;57:559-66.Halushka MK, Selvin E, Lu J, Macgregor AM, Cornish TC. Use of human vascular tissue microarrays for measurement of advanced glycation endproducts. J Histochem Cytochem.2009;57:559-66.Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, Lakatta EG. Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker. Circulation.2001;104:1464-70.Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, Lakatta EG. Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker. Circulation.2001;104:1464-70.Coll B, Feinstein SB. Carotid intima-media thickness measurements: techniques and clinical relevance. Curr Atheroscler Rep. 2008;10:444–450.Coll B, Feinstein SB. Carotid intima-media thickness measurements: techniques and clinical relevance. Curr Atheroscler Rep. 2008;10:444–450.Барбараш ОЛ, Авраменко ОЕ, Осокина АВ, Сумин АН, Веремеев АВ. Роль провоспалительных факторов в оценке прогноза больных с прогрессирующей стенокардией в сочетании с сахарным диабетом 2 типа. Сахарный диабет. 2012;4:39–45Барбараш ОЛ, Авраменко ОЕ, Осокина АВ, Сумин АН, Веремеев АВ. Роль провоспалительных факторов в оценке прогноза больных с прогрессирующей стенокардией в сочетании с сахарным диабетом 2 типа. Сахарный диабет. 2012;4:39–45Willemsen S, Hartog JW, Hummel YM, Posma JL, van Wijk LM, van DJ Veldhuisen, Voors AA. Сlinical and prognostic value of advanced glycation end products in chronic heart failure. European Heart Journal 2007;28:2879–2885.Willemsen S, Hartog JW, Hummel YM, Posma JL, van Wijk LM, van DJ Veldhuisen, Voors AA. Сlinical and prognostic value of advanced glycation end products in chronic heart failure. European Heart Journal 2007;28:2879–2885.Lautenslager GT, Shearman CW, Hud E, Cohen MP. Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin. Metabolism.2011;60(12):Lautenslager GT, Shearman CW, Hud E, Cohen MP. Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin. Metabolism.2011;60(12):Yan SF, D'Agati V, Schmidt AM, Ramasamy R. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging. Curr Mol Med. 2007 Dec;7(8):699-710.1683-1691.Yan SF, D'Agati V, Schmidt AM, Ramasamy R. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging. Curr Mol Med. 2007 Dec;7(8):699-710.1683-1691.Nin JW, Jorsal A. Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes. Diabetes Care. 2011;34:442–447,Nin JW, Jorsal A. Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes. Diabetes Care. 2011;34:442–447,Hegab Z, Gibbons S, Neyses L, Mamas M. Role of advanced glucation end products in cardiovascular disease. World J.Cardiol.2012;4(4):90-102.Hegab Z, Gibbons S, Neyses L, Mamas M. Role of advanced glucation end products in cardiovascular disease. World J.Cardiol.2012;4(4):90-102.Reddy GK. AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. Microvasc Res. 2004;68(2):132-42.Reddy GK. AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. Microvasc Res. 2004;68(2):132-42.Lapolla A. Nonenzymatically glycated lipoprotein Apo-AI in plasma of diabetic and nephropathic patients. Ann N Y Acad Sci 2007;26:295-299Lapolla A. Nonenzymatically glycated lipoprotein Apo-AI in plasma of diabetic and nephropathic patients. Ann N Y Acad Sci 2007;26:295-299Hoang A. Advanced glycation end-products of apolipoprotein Apo-AI impairs its anti-atherogenic properties. Diabetologia 2007;50:1770-1779Hoang A. Advanced glycation end-products of apolipoprotein Apo-AI impairs its anti-atherogenic properties. Diabetologia 2007;50:1770-1779Low H, Hoang A, Forbes J. Advanced glycation end-products and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models. Diabetologia 2012;55:2513-2521Low H, Hoang A, Forbes J. Advanced glycation end-products and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models. Diabetologia 2012;55:2513-2521Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004;63(4):582-92.Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004;63(4):582-92.Linden E, Cai W, He JC, Xue C, Li Z, Winston J, Vlassara H, Uribarri J. Endothelial Dysfunction in Patients with Chronic Kidney Disease Results from Advanced Glycation End Products (AGE)-Mediated Inhibition of Endothelial Nitric Oxide Synthase through RAGE Activation. Clin J Am Soc Nephrol. 2008; 3(3): 691–698.Linden E, Cai W, He JC, Xue C, Li Z, Winston J, Vlassara H, Uribarri J. Endothelial Dysfunction in Patients with Chronic Kidney Disease Results from Advanced Glycation End Products (AGE)-Mediated Inhibition of Endothelial Nitric Oxide Synthase through RAGE Activation. Clin J Am Soc Nephrol. 2008; 3(3): 691–698.Sugimoto K., Yasujima M., Yagihashi S. Role of advanced glucation end products in diabetic neuropathy. Curr. Pharm. Des. 2008;14(10):953-61.Sugimoto K., Yasujima M., Yagihashi S. Role of advanced glucation end products in diabetic neuropathy. Curr. Pharm. Des. 2008;14(10):953-61.Hou FF, Ren H, Owen WF, Guo ZJ, Chen PY, Schmidt AM, Miyata T, Zhang X: Enhanced expression of receptor for advanced glycation end products in chronic kidney disease. J Am Soc Nephrol.2007;15:1889–1896.Hou FF, Ren H, Owen WF, Guo ZJ, Chen PY, Schmidt AM, Miyata T, Zhang X: Enhanced expression of receptor for advanced glycation end products in chronic kidney disease. J Am Soc Nephrol.2007;15:1889–1896.Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H. Circulating glycotoxins and dietary advanced glycation endproducts: Two links to inflammatory response, oxidative stress and aging. J Gerontol Med Sci 200;762:427–433.Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H. Circulating glycotoxins and dietary advanced glycation endproducts: Two links to inflammatory response, oxidative stress and aging. J Gerontol Med Sci 200;762:427–433.Hartog JW, Voors AA,Bakker SJ. Advanced glycation endproducts and heart failure:pathophysiology and clinical implications. Eur J Heart Fail 2007;9:1146-1155Hartog JW, Voors AA,Bakker SJ. Advanced glycation endproducts and heart failure:pathophysiology and clinical implications. Eur J Heart Fail 2007;9:1146-1155Simm A, Wagner J, Gursinsky T, Nass N, Friedrich I. Advanced glycation eandproducts:a biomarker for age as an outcome predictor after cardiac surgery? Exp Gerontol 2007;42:668-675Simm A, Wagner J, Gursinsky T, Nass N, Friedrich I. Advanced glycation eandproducts:a biomarker for age as an outcome predictor after cardiac surgery? Exp Gerontol 2007;42:668-675Semba RD, Ferrucci L, Sun K, Beck J, Dalal M, Varadhan R, Walston J, Guralnik JM, Fried LP. Advanced glycation end products and their circulating receptorspredict cardiovascular disease mortality in older community dwelling women. Aging Clin Exp Res. 2009; 21(2): 182–190.Semba RD, Ferrucci L, Sun K, Beck J, Dalal M, Varadhan R, Walston J, Guralnik JM, Fried LP. Advanced glycation end products and their circulating receptorspredict cardiovascular disease mortality in older community dwelling women. Aging Clin Exp Res. 2009; 21(2): 182–190.Maria F, Hunt KJ, Baker NL, Lachin J, Nathan DM. Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes. Diabetes, 2011;60;582-588Maria F, Hunt KJ, Baker NL, Lachin J, Nathan DM. Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes. Diabetes, 2011;60;582-588Koyama Y. Soluble receptor for advanced glycation endproducts is a prognostic factor for heart failure. J Card Fail 2008;14:133-139Koyama Y. Soluble receptor for advanced glycation endproducts is a prognostic factor for heart failure. J Card Fail 2008;14:133-139Raposeiras-Roubin S. Relation of soluble receptor for advanced glycation endproducts to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score. Am J Cardiol. 2011;107:938-944Raposeiras-Roubin S. Relation of soluble receptor for advanced glycation endproducts to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score. Am J Cardiol. 2011;107:938-944Raposeiras-Roubin S. Solible receptor of advanced glycation endproducts levels are related Eur J Heart Fail. 2010;12:1092-1100Raposeiras-Roubin S. Solible receptor of advanced glycation endproducts levels are related Eur J Heart Fail. 2010;12:1092-1100

The authors declare that there are no conflicts of interest present.